1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Basic information
- Product Name:
- 1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-
- Synonyms:
-
- 1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-
- Sitagliptin Impurity 59 (Sitagliptin Tablets EP Impurity FP-B)
- CAS:
- 2805078-75-3
- MF:
- C16H13F6N5O2
- MW:
- 421.3
- Mol File:
- 2805078-75-3.mol
More
Less
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Chemical Properties
- Density
- 1.67±0.1 g/cm3(Predicted)
- solubility
- DMSO (Slightly), Methanol (Slightly, Heated)
- pka
- 12.02±0.40(Predicted)
- form
- Solid
- color
- White to Off-White
More
Less
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Usage And Synthesis
Uses
Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes.
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-Supplier
S.Z. PhyStandard Bio-Tech. Co., Ltd.
- Tel
- 0755-4000505016 13380397412
- 3001272453@qq.com
Hubei Yangxin Medical Technology Co., Ltd.
- Tel
- 15374522761
- 3003392093@yongstandards.com
QUALITY CONTROL SOLUTIONS LTD.
- Tel
- +86-0755-66853366 +86-13670046396
- export03@qcsrm.com
Cato Research Chemicals Inc.
- Tel
- 020-81960175-877 18933936954
- tianwen.zhan@cato-chem.com
Foshan Heshuo Pharm technology Co., ltd
- Tel
- 15363639686
- heshuoyiyao@hotmail.com
More
Less
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-(2805078-75-3)Related Product Information
- Sitagliptin Impurity 1
- (R)-3-AMino-4-(2,4,5-trifluoro-phenyl)-butyric acid hydrochloride
- Acetic acid, 2-chloro-, 2-(2-chloroacetyl)hydrazide
- Benzenebutanoic acid, β-[[(3R)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]amino]-2,4,5-trifluoro-, (βR)-
- tert-Butyl ((R)-4-Oxo-4-(((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)amino)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate
- BOC-(S)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID
- BLDAVCZELRQXFP-OWOJBTEDSA-N
- Sitagliptin N-Boc IMpurity
- Sitagliptin Defuoro IMpurity 3
- (R)-3-Amino-4-(2,4,5-trifluorophenyl)butyric acid
- (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
- Sitagliptin DeaMino IMpurity 1